198 related articles for article (PubMed ID: 37360372)
1. Outcomes in children with rheumatic diseases following COVID-19 vaccination and infection: data from a large two-center cohort study in Thailand.
Lerkvaleekul B; Charuvanij S; Sukharomana M; Pirojsakul K; Kamolwatwong M; Vilaiyuk S
Front Pediatr; 2023; 11():1194821. PubMed ID: 37360372
[TBL] [Abstract][Full Text] [Related]
2. Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING).
Ma M; Santosa A; Fong W; Chew LC; Low AH; Law A; Poh YJ; Yeo SI; Leung YY; Ng VW; Koh JZ; Tay SH; Mak A; Teng GG; Xu C; Tang JG; Kong KO; Angkodjojo S; Goh WR; Chuah TY; Roslan NE; Arkachaisri T; Teh KL; Sriranganathan M; Tan TC; Phang KF; Yap QV; Chan YH; Cheung PP; Lahiri M
J Autoimmun; 2023 Jan; 134():102959. PubMed ID: 36473406
[TBL] [Abstract][Full Text] [Related]
3. Impact of COVID-19 Pandemic on Patients With Rheumatic Diseases in Medina, Saudi Arabia: An Observational Cross-Sectional Study.
Safar Alsofyani I; Samman BS; Alhubayshi SS; Ellahi AT; Alsaedi AB; Almansour M
Cureus; 2024 May; 16(5):e60128. PubMed ID: 38864060
[TBL] [Abstract][Full Text] [Related]
4. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and factors associated with flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: a national cohort study.
Fong W; Woon TH; Chew LC; Low A; Law A; Poh YJ; Yeo SI; Leung YY; Ma M; Santosa A; Kong KO; Xu C; Teng GG; Mak A; Tay SH; Chuah TY; Roslan NE; Angkodjojo S; Phang KF; Sriranganathan M; Tan TC; Cheung P; Lahiri M
Adv Rheumatol; 2023 Aug; 63(1):38. PubMed ID: 37528453
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
7. Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine.
Spinelli FR; Favalli EG; Garufi C; Cornalba M; Colafrancesco S; Conti F; Caporali R
Arthritis Res Ther; 2022 Jan; 24(1):21. PubMed ID: 35016701
[TBL] [Abstract][Full Text] [Related]
8. Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination.
Šinkovec Savšek T; Zajc Avramovič M; Avčin T; Korva M; Avšič Županc T; Toplak N
Pediatr Rheumatol Online J; 2023 May; 21(1):46. PubMed ID: 37208721
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications.
Heshin-Bekenstein M; Ziv A; Toplak N; Hagin D; Kadishevich D; Butbul YA; Saiag E; Kaufman A; Shefer G; Sharon O; Pel S; Elkayam O; Uziel Y
Rheumatology (Oxford); 2022 Nov; 61(11):4263-4272. PubMed ID: 35179569
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune rheumatic diseases and COVID-19 vaccination: a retrospective cross-sectional study from Astana.
Rutskaya-Moroshan K; Abisheva S; Sarsenova M; Ogay V; Vinnik T; Aubakirova B; Abisheva A
Reumatologia; 2024; 62(1):26-34. PubMed ID: 38558898
[TBL] [Abstract][Full Text] [Related]
11. The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review.
Xie Y; Liu Y; Liu Y
Front Immunol; 2022; 13():919979. PubMed ID: 35860285
[TBL] [Abstract][Full Text] [Related]
12. Association of COVID-19 Vaccinations With Flares of Systemic Rheumatic Disease: A Case-Crossover Study.
Braverman G; Barbhaiya M; Nong M; Bykerk VP; Hupert N; Lewis C; Mandl LA
Arthritis Care Res (Hoboken); 2024 May; 76(5):733-742. PubMed ID: 38163750
[TBL] [Abstract][Full Text] [Related]
13. Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination.
Watad A; De Marco G; Mahajna H; Druyan A; Eltity M; Hijazi N; Haddad A; Elias M; Zisman D; Naffaa ME; Brodavka M; Cohen Y; Abu-Much A; Abu Elhija M; Bridgewood C; Langevitz P; McLorinan J; Bragazzi NL; Marzo-Ortega H; Lidar M; Calabrese C; Calabrese L; Vital E; Shoenfeld Y; Amital H; McGonagle D
Vaccines (Basel); 2021 Apr; 9(5):. PubMed ID: 33946748
[TBL] [Abstract][Full Text] [Related]
14. Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey.
Rider LG; Parks CG; Wilkerson J; Schiffenbauer AI; Kwok RK; Noroozi Farhadi P; Nazir S; Ritter R; Sirotich E; Kennedy K; Larche MJ; Levine M; Sattui SE; Liew JW; Harrison CO; Moni TT; Miller AK; Putman M; Hausmann J; Simard JF; Sparks JA; Miller FW;
Rheumatology (Oxford); 2022 Jun; 61(SI2):SI143-SI150. PubMed ID: 35460240
[TBL] [Abstract][Full Text] [Related]
15. A flare of Still's disease following COVID-19 vaccination in a 34-year-old patient.
Jeon YH; Lim DH; Choi SW; Choi SJ
Rheumatol Int; 2022 Apr; 42(4):743-748. PubMed ID: 34797392
[TBL] [Abstract][Full Text] [Related]
16. Safety of COVID-19 vaccines and disease flares after vaccines in children with rheumatic disease.
Arslanoglu Aydin E; Baglan E; Bagrul I; Tuncez S; Ozdel S; Bulbul M
Postgrad Med; 2022 Aug; 134(6):616-621. PubMed ID: 35535525
[TBL] [Abstract][Full Text] [Related]
17. New-Onset Psoriatic Arthritis Following COVID-19 mRNA Vaccination in a Psoriatic Patient Under Anti-tumor Necrosis Factor Alpha Biologic Treatment: What Now?
Sousa M; Gersão S; Sousa HB
Cureus; 2023 Dec; 15(12):e50723. PubMed ID: 38234927
[TBL] [Abstract][Full Text] [Related]
18. Is vaccination against COVID-19 associated with autoimmune rheumatic disease flare? A self-controlled case series analysis.
Nakafero G; Grainge MJ; Card T; Mallen CD; Nguyen Van-Tam JS; Williams HC; Abhishek A
Rheumatology (Oxford); 2023 Apr; 62(4):1445-1450. PubMed ID: 36048896
[TBL] [Abstract][Full Text] [Related]
19. Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies.
Boekel L; Steenhuis M; Hooijberg F; Besten YR; van Kempen ZLE; Kummer LY; van Dam KPJ; Stalman EW; Vogelzang EH; Cristianawati O; Keijzer S; Vidarsson G; Voskuyl AE; Wieske L; Eftimov F; van Vollenhoven R; Kuijpers TW; van Ham SM; Tas SW; Killestein J; Boers M; Nurmohamed MT; Rispens T; Wolbink G
Lancet Rheumatol; 2021 Nov; 3(11):e778-e788. PubMed ID: 34396154
[TBL] [Abstract][Full Text] [Related]
20. Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection.
Uziel Y; Moshe V; Onozo B; Kulcsár A; Tróbert-Sipos D; Akikusa JD; Salviato Pileggi G; Maritsi D; Kasapcopur O; Rodrigues M; Smerla R; Rigante D; Makay B; Atsali E; Wulffraat N; Toplak N;
Vaccine; 2020 Feb; 38(9):2198-2201. PubMed ID: 31987692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
